Towarzystwo Funduszy Inwestycyjnych PZU SA Purchases 13,046 Shares of Axon Enterprise, Inc $AXON

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 363.1% in the third quarter, HoldingsChannel reports. The firm owned 16,639 shares of the biotechnology company’s stock after purchasing an additional 13,046 shares during the quarter. Axon Enterprise accounts for approximately 2.8% of Towarzystwo Funduszy Inwestycyjnych PZU SA’s holdings, making the stock its 12th biggest holding. Towarzystwo Funduszy Inwestycyjnych PZU SA’s holdings in Axon Enterprise were worth $11,941,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Stone House Investment Management LLC bought a new position in Axon Enterprise in the third quarter worth $29,000. New Millennium Group LLC bought a new stake in shares of Axon Enterprise during the 3rd quarter valued at $29,000. Root Financial Partners LLC purchased a new stake in shares of Axon Enterprise in the 3rd quarter worth about $34,000. Darwin Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the 2nd quarter worth about $37,000. Finally, Elevation Point Wealth Partners LLC bought a new position in shares of Axon Enterprise in the 2nd quarter worth about $56,000. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on AXON shares. Royal Bank Of Canada lowered their price target on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research report on Wednesday, February 25th. Morgan Stanley decreased their target price on shares of Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Citigroup reiterated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, February 25th. Craig Hallum reissued a “buy” rating and issued a $820.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 25th. Finally, Robert W. Baird set a $800.00 price target on Axon Enterprise in a research note on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $762.93.

Insider Transactions at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the sale, the chief executive officer owned 3,090,997 shares of the company’s stock, valued at $1,546,240,339.28. This trade represents a 0.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Jennifer H. Mak sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $573.45, for a total transaction of $860,175.00. Following the completion of the transaction, the chief accounting officer owned 12,240 shares of the company’s stock, valued at approximately $7,019,028. The trade was a 10.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 24,634 shares of company stock worth $13,803,095. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Price Performance

AXON opened at $496.18 on Friday. The firm has a market cap of $39.89 billion, a PE ratio of 326.44, a P/E/G ratio of 10.66 and a beta of 1.46. The stock has a 50-day moving average price of $531.08 and a 200-day moving average price of $610.44. Axon Enterprise, Inc has a 1 year low of $396.41 and a 1 year high of $885.91. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, beating the consensus estimate of $1.60 by $0.55. The company had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. Axon Enterprise’s revenue for the quarter was up 38.5% on a year-over-year basis. During the same period in the prior year, the firm posted $2.08 EPS. Sell-side analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.